Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide-Reference-Cited by-同舟云学术

Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide

Published:2017-02-28 Issue:10 Volume:58 Page:2511-2513
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Oka Satoko¹,Ono Kazuo²,Nohgawa Masaharu¹

Affiliation:

1. Division of Hematology, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan;

2. Division of Pathology, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1295146

Reference14 articles.

1. New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

2. Genetic complexity of myeloproliferative neoplasms

3. The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

4. Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia;International Journal of Molecular Sciences;2023-03-17

2. Myeloid neoplasm with isolated del(5q) and the MPLW515L mutation fulfills the WHO diagnostic criteria for ET;International Journal of Hematology;2020-04-03

3. Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide;Leukemia & Lymphoma;2017-07-11